Followers | 256 |
Posts | 18838 |
Boards Moderated | 3 |
Alias Born | 12/02/2014 |
Saturday, December 03, 2016 6:07:47 PM
Executive Director, Chairman of Audit Committee and Chairman of Nomination/Compensation Committee,Digital Brand Media & Marketing Group, Inc.
Ms. Linda Perry served as the Chief Executive Officer and President of Digital Brand Media & Marketing Group, Inc. from September 1, 2003 to March 31, 2010. Ms. Perry served as President of GWR Enterprises, Inc., from 1997 to 1999, focused on new business opportunities through private equity and special situation investments. She was a Senior Executive at Exxon Corporation holding general management positions in finance, marketing and organization (including corporate governance, management succession, and executive compensation) with worldwide responsibility, from 1983 to 1996. Ms. Perry has an extensive career in global and entrepreneurial businesses. Prior to that time, from 2001-2002, she was the senior advisor to the Board of Directors of The Balli Group, where her role was to integrate the acquisition of Klockner & Co. As Chief Executive Officer and a Director of Far East Challenges, Plc, Ms. Perry, in conjunction with the shareholders, led the strategic Director Development of RTGV's current enterprise. she served as a Director of Churchill Insurance Group, Plc., a division of the Credit Suisse Group from 1999 to 2001. She has been an Executive Director at Digital Brand Media & Marketing Group, Inc. (alternate name: RTG Ventures Inc.) since April 1, 2010. Ms. Perry has been a visiting lecturer/professor at IMD, Lausanne, Switzerland, INSEAD, Fontainbleau, France and the Stern School of Business at New York University, throughout her career. Ms. Perry holds a Masters in Business Administration from Harvard University.
http://www.bloomberg.com/research/stocks/people/person.asp?personId=8683659&privcapId=3576388
Recent DBMM News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/16/2024 09:32:32 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 11/29/2023 09:31:08 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/17/2023 09:15:45 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM